124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice - Wikidata - wikimedia - TriplyDB

124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice

124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice

http://www.wikidata.org/entity/Q34206802

about

Molecular Imaging in Genetic Medicine Use of (64)Cu-labeled fibronectin domain with EGFR-overexpressing tumor xenograft: molecular imaging.Imaging in neurooncology Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method.Tumor imaging by means of proteolytic activation of cell-penetrating peptides Design and preclinical evaluation of a 99mTc-labelled diabody of mAb J591 for SPECT imaging of prostate-specific membrane antigen (PSMA).Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells.Minibody-indocyanine green based activatable optical imaging probes: the role of short polyethylene glycol linkers Target mediated disposition of T84.66, a monoclonal anti-CEA antibody: application in the detection of colorectal cancer xenografts Optical imaging-guided cancer therapy with fluorescent nanoparticles ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies).Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas.Development of 124I immuno-PET targeting tumor vascular TEM1/endosialin.Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.Quantitative serial imaging of an 124I anti-CEA monoclonal antibody in tumor-bearing mice.Evaluation of two internalizing carcinoembryonic antigen reporter genes for molecular imaging Estimation of the minimum detectable activity of preclinical PET imaging systems with an analytical method.A method of image registration for small animal, multi-modality imaging Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments Cytotoxic enhancement of a bispecific diabody by format conversion to tandem single-chain variable fragment (taFv): the case of the hEx3 diabody.Evaluation of the anti-HER2 C6.5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatment Imaging and cancer: a review.Generation and characterization of a diabody targeting the αvβ6 integrin.Site-specific conjugation of monodispersed DOTA-PEGn to a thiolated diabody reveals the effect of increasing peg size on kidney clearance and tumor uptake with improved 64-copper PET imaging.A fully human scFv phage display library for rapid antibody fragment reformatting Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PET.Recent trends in antibody-based oncologic imaging Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-life Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges.Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.Protein-based tumor molecular imaging probes.Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors Impact of expression system on the function of the C6.5 diabody PET radiotracer Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance.

P2860

Q26749125-F94AA878-5C3F-43DE-A725-ED8438D6ABB3 Q30511916-39E1AB42-3254-41F7-8BBC-7CC1951314F2 Q30989939-4A4C6029-D50C-4879-9DDE-9D4B03B14FF5 Q33389445-57DB458D-0801-433F-B8CA-90B56F80FD22 Q33569121-7285E6AD-0F73-455F-8089-AA27CB33D27D Q33586706-64C68694-D28C-4879-A20D-ABF2DC5BDCF7 Q33620053-27CF5F1B-19BF-45E2-B78A-9EFA2783C8FA Q33636135-C2A1B882-235F-4AD3-9973-09C9EAEA71E8 Q33688233-C25C3140-59A8-4BD0-BA3F-6D1FE9905CB6 Q33731037-E65D97AA-939D-4DD5-83B9-3A1AD0C56CD6 Q33738721-45D6E7ED-5BD8-41CB-AA4B-747189CA9BD6 Q33781006-007E06D5-E50B-4AF1-856A-5F9151CA9583 Q33872675-C8D1A421-B43C-48CC-8F71-41E25EC796C4 Q34117552-C84C23E1-CEBF-42C1-8BD0-AF72996CAC6C Q34134336-1E3E058D-73CD-4862-822A-1DF91A3ED0B0 Q34164704-2B871EC4-63AA-40F0-9AC1-8FB644F5EE6F Q34328761-2CD98991-0398-49F9-9C12-6D81DC49F330 Q34354220-0D320742-F0EE-4C2C-92C1-5BECE90FA532 Q34367250-1EEA4C97-7482-4FC3-B394-03C9A1E721CC Q34421484-CA06B352-32FB-4232-846E-A5CB806F044A Q34459696-0AEE5C00-9BE2-4868-A4C7-8FADE6906FA0 Q34503084-4EF77D90-7E6B-4C52-9A47-5B6D1F55AA50 Q34694211-434B9B74-61A8-4524-A7E3-1E3FF23A2F5F Q34977050-CF823CB7-E8F2-4176-80E0-C64116AB2532 Q34984328-A5AAD78B-B68F-4CB0-9C4D-261F19A2435C Q35002038-E8F26753-5779-4C8B-B71E-8B004C830C40 Q35635839-B1CF3FB2-A7F7-44C1-8948-73CED5B1AEC7 Q35636908-8518C44B-5517-4B05-842C-554E9BAB7B47 Q35643425-3E5DE22A-21AE-40E5-A9DF-BB798861277F Q35650818-2251B907-8B39-4159-B084-23E7CAE0F718 Q35785799-63B599C9-AB6A-4BAB-9A16-335B4758880C Q36080399-A754FCF4-6BBC-4238-9934-2E38BD5A70BC Q36096813-1A4A4A0A-0D0B-45A0-941D-C8A5A6BF7B87 Q36216009-FCE66D55-1669-4DFB-A602-C28E284E478F Q36339722-723FF518-5448-421B-ADD6-1C0AF60F4DD6 Q36690711-76BD1BF8-9118-4312-A970-80EFB146D826 Q36742911-588AEA0D-A4FC-42D3-971D-CFA0300235ED Q37101581-B53FBB98-AD0D-4C80-A2B5-2DFF4912E7B7 Q37142836-2B92AA75-DFFE-4A5E-8A2C-7A8277DB3047 Q37187003-A6F9B0F3-E272-4A69-875C-56F3953DE34A

P2860

124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice

http://www.wikidata.org/entity/Q34206802

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

124I-labeled engineered anti-C ...... of xenografts in athymic mice

@ast

124I-labeled engineered anti-C ...... of xenografts in athymic mice

@en

124I-labeled engineered anti-C ...... of xenografts in athymic mice

@nl

type

label

124I-labeled engineered anti-C ...... of xenografts in athymic mice

@ast

124I-labeled engineered anti-C ...... of xenografts in athymic mice

@en

124I-labeled engineered anti-C ...... of xenografts in athymic mice

@nl

prefLabel

124I-labeled engineered anti-C ...... of xenografts in athymic mice

@ast

124I-labeled engineered anti-C ...... of xenografts in athymic mice

@en

124I-labeled engineered anti-C ...... of xenografts in athymic mice

@nl

P1433

Q34206802-97F9E5E1-054B-4A44-94E5-672E0517CDBE

P1476

Q34206802-81562019-F60E-4C44-BFA8-1122AF9A88E9

P2093

Q34206802-57B28948-349E-49BC-8623-95709ACDB04E

Q34206802-76153B32-CC90-4913-A160-AB335CA1A9A6

Q34206802-7793BF7D-67EA-466F-A0D0-D372CD8FB79D

Q34206802-90F2E02C-8479-4D56-9230-9B907A3C4479

Q34206802-96BF0A43-9F9A-4E88-B0E0-C0BBDEFBD5A2

Q34206802-CCE4758D-CE42-489E-BF77-E39131BAFFC7

Q34206802-D0849D45-511A-4511-AC76-A52AF1B602C7

Q34206802-EF558AA2-714A-453D-A321-5378259C3803

Q34206802-F91E901A-0A22-4E4B-8779-E2E6480E2F3E

Q34206802-FC8CA0B6-5053-429D-B660-6149DFD84D24

P2860

Q34206802-04A2921C-6071-471B-AAC8-5C9C72F4B66D

Q34206802-108EBEB5-3D29-43B3-B730-D0805AFD3862

Q34206802-16E93220-5022-43E7-8BFD-CAD7BA016456

Q34206802-2787305E-D233-49A4-A246-6BF2F052D801

Q34206802-27EBEEA4-37DE-46E8-B93D-F9E9ADAB585D

Q34206802-3B622C60-5A5E-4D34-8C0C-536BA9FAD13B

Q34206802-52E35EC4-4D43-435A-996B-562A3CE8D37C

Q34206802-6A8D6BB8-C63C-478F-996E-4BF616973C38

Q34206802-7A16BE41-1AE2-483A-B5A0-75EC1E1B18AC

Q34206802-7E536FA1-DEDE-48EF-971C-AEE5AEB07AEF

P304

Q34206802-C285C1B4-4777-49E5-9E28-6857D78641E2

P31

Q34206802-3D416A92-8C05-437E-858D-4ED11E0883D1

P407

Q34206802-D5C24FBA-1D66-44F7-B2B8-9E813904E9AE

P433

Q34206802-7DBC7D8A-BCAF-4E09-A115-F88A7050B38E

P478

Q34206802-6C2C69F0-C20C-44B6-A06D-14FA0BBF395B

P577

Q34206802-C2318410-2901-4C22-B09A-26BF22D4F0A9

P698

Q34206802-E38D8FB2-6F0D-4DCE-9A33-B559264BFC13

P921

Q34206802-A109F4D9-2292-47DB-830D-93464762339B

P932

Q34206802-281FBE8C-0DFA-4420-BE48-1D2C34999BBF

P1433

The Journal of Nuclear Medicine

P1476

124I-labeled engineered anti-C ...... of xenografts in athymic mice

@en

P2093

Andrew A Raubitschek

http://www.w3.org/2001/XMLSchema#string

Anna M Wu

http://www.w3.org/2001/XMLSchema#string

Arion F Chatziioannou

http://www.w3.org/2001/XMLSchema#string

Gobalakrishnan Sundaresan

http://www.w3.org/2001/XMLSchema#string

John E Shively

http://www.w3.org/2001/XMLSchema#string

Lawrence E Williams

http://www.w3.org/2001/XMLSchema#string

Paul J Yazaki

http://www.w3.org/2001/XMLSchema#string

Ronald D Finn

http://www.w3.org/2001/XMLSchema#string

Sanjiv S Gambhir

http://www.w3.org/2001/XMLSchema#string

Steven M Larson

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of genetic engineering on the pharmacokinetics of antibodies.

Designer genes: recombinant antibody fragments for biological imaging.

Quantitation in positron emission computed tomography: 1. Effect of object size.

Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging.

High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment

Expression, purification, and characterization of a two domain carcinoembryonic antigen minigene (N-A3) in pichia pastoris. The essential role of the N-domain.

Carcinoembryonic antigen as a target cancer antigen for radiolabeled antibodies: prospects for cancer imaging and therapy.

Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.

Single-chain Fv radioimmunotargeting.

High-resolution positron emission tomography of human ovarian cancer in nude rats using 124I-labeled monoclonal antibodies.

P304

1962-1969

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14660722

http://www.w3.org/2001/XMLSchema#string

P921

P932

4167879

http://www.w3.org/2001/XMLSchema#string